SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (208)1/22/1997 9:47:00 PM
From: James Silverman   of 6136
 
I wonder if VRTX being partnered with GLX will be a tough team, in terms of them bundling the various AIDS drugs together to the managed care sectors.

Personally, I was encouraged to see trials beginning on the AGPH/VRTX PI combo's. Could be a nice combo: lowered side effects, superior regimen, both cross BB barrier readily and so forth.

Looks like this SD stock is getting more and more overvalued every day-this shareholder isn't complaining.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News